Surmodics Inc (SRDX)
34.94
-0.12
(-0.34%)
USD |
NASDAQ |
May 21, 16:00
34.94
0.00 (0.00%)
After-Hours: 20:00
Surmodics Enterprise Value: 488.50M for May 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 20, 2024 | 488.50M |
| May 17, 2024 | 482.22M |
| May 16, 2024 | 474.52M |
| May 15, 2024 | 467.11M |
| May 14, 2024 | 459.12M |
| May 13, 2024 | 451.28M |
| May 10, 2024 | 447.14M |
| May 09, 2024 | 449.42M |
| May 08, 2024 | 439.01M |
| May 07, 2024 | 443.01M |
| May 06, 2024 | 451.71M |
| May 03, 2024 | 451.85M |
| May 02, 2024 | 481.22M |
| May 01, 2024 | 463.83M |
| April 30, 2024 | 354.88M |
| April 29, 2024 | 357.16M |
| April 26, 2024 | 361.73M |
| April 25, 2024 | 361.73M |
| April 24, 2024 | 360.30M |
| April 23, 2024 | 372.42M |
| April 22, 2024 | 350.60M |
| April 19, 2024 | 366.29M |
| April 18, 2024 | 364.86M |
| April 17, 2024 | 366.72M |
| April 16, 2024 | 367.86M |
| Date | Value |
|---|---|
| April 15, 2024 | 365.29M |
| April 12, 2024 | 373.56M |
| April 11, 2024 | 383.26M |
| April 10, 2024 | 382.69M |
| April 09, 2024 | 384.26M |
| April 08, 2024 | 380.55M |
| April 05, 2024 | 374.70M |
| April 04, 2024 | 376.13M |
| April 03, 2024 | 372.99M |
| April 02, 2024 | 373.13M |
| April 01, 2024 | 386.40M |
| March 31, 2024 | 406.93M |
| March 28, 2024 | 411.95M |
| March 27, 2024 | 404.27M |
| March 26, 2024 | 395.87M |
| March 25, 2024 | 384.90M |
| March 22, 2024 | 388.04M |
| March 21, 2024 | 396.58M |
| March 20, 2024 | 404.55M |
| March 19, 2024 | 389.89M |
| March 18, 2024 | 385.33M |
| March 15, 2024 | 395.30M |
| March 14, 2024 | 397.29M |
| March 13, 2024 | 406.83M |
| March 12, 2024 | 412.24M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
245.03M
Minimum
Mar 23 2023
771.71M
Maximum
Nov 08 2021
512.37M
Average
498.86M
Median
Jan 14 2020
Enterprise Value Benchmarks
| Boston Scientific Corp | 119.32B |
| ResMed Inc | 32.90B |
| Glaukos Corp | 5.514B |
| Accuray Inc | 271.83M |
| Alphatec Holdings Inc | 1.913B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.247M |
| Revenue (Quarterly) | 31.96M |
| Total Expenses (Quarterly) | 31.30M |
| EPS Diluted (Quarterly) | 0.02 |
| Gross Profit Margin (Quarterly) | 45.77% |
| Profit Margin (Quarterly) | 0.77% |
| Earnings Yield | 2.72% |
| Operating Earnings Yield | 3.75% |
| Normalized Earnings Yield | 2.484 |